Charles A. Deignan, Clearside Biomedical, Inc.'s Chief Financial Officer, recently acquired 10,000 shares of the company. The buys took place at $1.36 per share, on March 15, 2019. Deignan now owns 76,356 shares of the company. Deignan operates out of Alpharetta, GA. Some additional info was provided as follows:
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Clearside Biomedical, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Clearside Biomedical Provides New Drug Application Update For Xipere - Aug. 22, 2019
Clearside Biomedical, Inc.'s CEO just picked up 100,000 shares - Aug. 8, 2019
Clearside Biomedical, Inc. Just Filed Its Quarterly Report: 12. Net Loss Per Sha... - Aug. 8, 2019
Clearside Biomedical Announces Second Quarter 2019 - Aug. 7, 2019